Experts ID new treatment for type 1 diabetes

12/20/2011 | Sydney Morning Herald (Australia), The

The depletion of heparan sulphate, a type of complex sugar, triggers the destruction of insulin-producing beta cells, a study in The Journal of Clinical Investigation showed. Researchers also found that autoimmune cells produce the enzyme heparanase, which degrades heparan sulphate in beta cells. "This has revealed a new understanding of the development of type 1 diabetes and has identified a new therapeutic strategy for preventing progression of the autoimmune disease and associated complications," researcher Dr. Charmaine Simeonovic said.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park